{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T05:12:03Z","timestamp":1773551523315,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40792-018-0522-4","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T06:57:50Z","timestamp":1536562670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report"],"prefix":"10.1186","volume":"4","author":[{"given":"Takeshi","family":"Fujishiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Mashiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosihito","family":"Masuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misuzu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Nakagohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"522_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607\u201320.","journal-title":"Lancet"},{"key":"522_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000267","volume":"7","author":"S Gillen","year":"2010","unstructured":"Gillen S, Schuster T, Meyer Zum B\u00fcschenfelde C, Friess H, Kleeff J. Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7:e1000267.","journal-title":"PLoS Med"},{"key":"522_CR3","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1053\/j.gastro.2013.01.078","volume":"144","author":"AS Paulson","year":"2013","unstructured":"Paulson AS, Tran Cao HS, Tempero MA, Lowy AM. Therapeutic advances in pancreatic cancer. Gastroenterology. 2013;144:1316\u201326.","journal-title":"Gastroenterology"},{"key":"522_CR4","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1245\/s10434-016-5707-0","volume":"24","author":"F Bednar","year":"2017","unstructured":"Bednar F, Zenati MS, Steve J, Winters S, Ocuin LM, Bahary N, et al. Analysis of predictors of resection and survival in locally advanced stage III pancreatic cancer: does the nature of chemotherapy regimen influence outcomes? Ann Surg Oncol. 2017;24:1406\u201313.","journal-title":"Ann Surg Oncol"},{"key":"522_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/jhbp.119","volume":"21","author":"SS Opendro","year":"2014","unstructured":"Opendro SS, Satoi S, Yanagimoto H, Yamamoto T, Toyokawa H, Hirooka S, et al. Role of adjuvant surgery in initially unresectable pancreatic cancer after long-term chemotherapy or chemoradiation therapy: survival benefit? J Hepatobiliary Pancreat Sci. 2014;21:695\u2013702.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"522_CR6","volume-title":"General rules for the study of pancreatic cancer 7th edition","author":"S Isaji","year":"2016","unstructured":"Isaji S. General rules for the study of pancreatic cancer 7th edition. Tokyo: Kanehara & Co.,Ltd.; 2016."},{"key":"522_CR7","volume-title":"Classification of pancreatic carcinoma 4th English edition","author":"S Isaji","year":"2017","unstructured":"Isaji S. Classification of pancreatic carcinoma 4th English edition. Tokyo: Kanehara & Co.,Ltd.; 2017."},{"key":"522_CR8","unstructured":"National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Pancreatic adenocarcinoma. Version 2. 2016. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf (accessed 24 Jan 2018)."},{"key":"522_CR9","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1245\/s10434-009-0409-5","volume":"16","author":"JN Vauthey","year":"2009","unstructured":"Vauthey JN, Dixon E. AHPBA\/SSO\/SSAT consensus conference on resectable and borderline resectable pancreatic cancer: rationale and overview of the conference. Ann Surg Oncol. 2009;16:1725\u20136.","journal-title":"Ann Surg Oncol"},{"key":"522_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00464-004-8165-x","volume":"19","author":"RC Liu","year":"2005","unstructured":"Liu RC, Traverso LW. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc. 2005;19:638\u201342.","journal-title":"Surg Endosc"},{"key":"522_CR11","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.gassur.2004.09.026","volume":"8","author":"M Shoup","year":"2004","unstructured":"Shoup M, Winston C, Brennan MF, Bassman D, Conlon KC. Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma? J Gastrointest Surg. 2004;8:1068\u201371.","journal-title":"J Gastrointest Surg"},{"key":"522_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s005340050148","volume":"7","author":"RE Jimenez","year":"2000","unstructured":"Jimenez RE, Warshaw AL, Fernandez-Del CC. Laparoscopy and peritoneal cytology in the staging of pancreatic cancer. J Hepato-Biliary-Pancreat Surg. 2000;7:15\u201320.","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"key":"522_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00280-009-1193-4","volume":"66","author":"K Nakachi","year":"2010","unstructured":"Nakachi K, Furuse J, Kinoshita T, Kawashima M, Ishii H, Ikeda M, et al. A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer. Cancer Chemother Pharmacol. 2010;66:527\u201334.","journal-title":"Cancer Chemother Pharmacol"},{"key":"522_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/bjc.2011.526","volume":"106","author":"D Goldstein","year":"2012","unstructured":"Goldstein D, Spry N, Cummins MM, Brown C, van Hazel GA, Carroll S, et al. The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine\u2013oxaliplatin integrated with concurrent 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer. Br J Cancer. 2012;106:61\u20139.","journal-title":"Br J Cancer"},{"key":"522_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/cncr.27723","volume":"119","author":"M Shinoto","year":"2013","unstructured":"Shinoto M, et al. Phase I trial of preoperative, short course carbon-ion radiotherapy for patients with resectable pancreatic cancer. Cancer. 2013;119:45\u201351.","journal-title":"Cancer"},{"key":"522_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/095530098141799","volume":"74","author":"K Ando","year":"1998","unstructured":"Ando K, Koike S, Kojima K, et al. Mouse skin reactions following fractionated iiradiation with carbon ions. Int J Radiat Biol. 1998;74:129\u201338.","journal-title":"Int J Radiat Biol"},{"key":"522_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.radonc.2012.08.009","volume":"105","author":"K Oonishi","year":"2012","unstructured":"Oonishi K, Cui X, Hirakawa H, et al. Different effects of carbon-ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells. Radiother Oncol. 2012;105:258\u201365.","journal-title":"Radiother Oncol"},{"key":"522_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2015.12.362","volume":"95","author":"M Shinoto","year":"2016","unstructured":"Shinoto M, Yamada S, Terashima K, Yasuda S, Shioyama Y, Honda H, et al. Carbon-ion radiation therapy with concurrent gemcitabine for patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2016;95:498\u2013504.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"522_CR19","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.ijrobp.2018.04.057","volume":"101","author":"S Kawashiro","year":"2018","unstructured":"Kawashiro S, Yamada S, Okamoto M, Ohno T, Nakano T, Shinoto M, et al. Multi-institutional study of carbon-ion radiotherapy for locally advanced pancreatic cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas. Int J Radiat Oncol Biol Phys. 2018;101:1212\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"522_CR20","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/archsurg.2011.152","volume":"146","author":"TR Donahue","year":"2011","unstructured":"Donahue TR, Isacoff WH, Hines OJ, Tomlinson JS, Farrell JJ, Bhat YM, et al. Downstaging chemotherapy and alteration in the classic computed tomography\/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery. Arch Surg. 2011;146:836\u201343.","journal-title":"Arch Surg"},{"key":"522_CR21","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1245\/s10434-015-4647-4","volume":"22","author":"E Sadot","year":"2015","unstructured":"Sadot E, Doussot A, O\u2019Reilly EM, Lowery MA, Goodman KA, Do RK, et al. FOLFIRINOX induction therapy for stage 3 pancreatic adenocarcinoma. Ann Surg Oncol. 2015;22:3512\u201321.","journal-title":"Ann Surg Oncol"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-018-0522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40792-018-0522-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-018-0522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T19:05:51Z","timestamp":1568055951000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-018-0522-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1186\/s40792-018-0522-4","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"112"}}